Phase II, randomized, multicenter, comparative study of peginterferon-alpha-2a (40 kD) (Pegasys) versus interferon alpha-2a (Roferon-A) in patients with treatment-naïve, chronic-phase chronic myelogenous leukemia (Q80206050)
Jump to navigation
Jump to search
scientific article published on 01 March 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II, randomized, multicenter, comparative study of peginterferon-alpha-2a (40 kD) (Pegasys) versus interferon alpha-2a (Roferon-A) in patients with treatment-naïve, chronic-phase chronic myelogenous leukemia |
scientific article published on 01 March 2007 |
Statements
Phase II, randomized, multicenter, comparative study of peginterferon-alpha-2a (40 kD) (Pegasys) versus interferon alpha-2a (Roferon-A) in patients with treatment-naïve, chronic-phase chronic myelogenous leukemia (English)
Jeffrey H Lipton
Nina Khoroshko
Anatoly Golenkov
Krishnan Nair
Digumarti Raghunadharao
Tim Brummendorf
Kisook Yoo
Bengt Bergstrom
Pegasys CML Study Group